Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > I think there's a big shark out there

<< Previous

Bullboard Posts

Next >>

Comment by WalkingDead01on Dec 28, 2020 4:35pm

104 Views

Post# 32188578

RE:RE:RE:RE:RE:I think there's a big shark out there

birch1 wrote: If this works, see you at $10 next year. Eyes seem to be on this in the US.

I agree ... $ 10 is very possible and we will find out quickly from the results and the reactions of the big investors. So far we end at .175 USD with a good volume of 665k.

<< Previous

Bullboard Posts

Next >>

Air Canada stock rises as service from Ottawa grows